STERIS plc
NYSE:STE

Watchlist Manager
STERIS plc Logo
STERIS plc
NYSE:STE
Watchlist
Price: 216.06 USD -0.03% Market Closed
Market Cap: 21.3B USD
Have any thoughts about
STERIS plc?
Write Note

Operating Margin
STERIS plc

18.2%
Current
14%
Average
4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
18.2%
=
Operating Profit
933.4m
/
Revenue
5.1B

Operating Margin Across Competitors

Country IE
Market Cap 21.3B USD
Operating Margin
18%
Country US
Market Cap 205.2B USD
Operating Margin
17%
Country US
Market Cap 193.1B USD
Operating Margin
26%
Country US
Market Cap 148.6B USD
Operating Margin
22%
Country US
Market Cap 132.9B USD
Operating Margin
18%
Country IE
Market Cap 109.9B USD
Operating Margin
19%
Country US
Market Cap 64.8B USD
Operating Margin
14%
Country DE
Market Cap 56.7B EUR
Operating Margin
12%
Country CN
Market Cap 325.5B CNY
Operating Margin
36%
Country US
Market Cap 42.2B USD
Operating Margin
28%
Country US
Market Cap 37.7B USD
Operating Margin
13%
No Stocks Found

STERIS plc
Glance View

Market Cap
21.3B USD
Industry
Health Care

STERRIS plc is a globally recognized leader in the field of infection prevention, surgical, and critical care solutions, committed to enhancing patient safety and healthcare efficiency. With a rich history spanning over 100 years, the company operates in more than 60 countries, offering a diverse range of products and services tailored to meet the needs of healthcare providers. STERIS’s innovative technologies, including sterilization and disinfection equipment, surgical tables, and integrated surgical suites, position it as a vital partner for hospitals and medical facilities striving to uphold high standards of patient care. This focus on innovation not only drives customer loyalty but also positions the company favorably in an industry that increasingly prioritizes safety and efficiency. For investors, STERIS presents a robust growth trajectory, bolstered by a strategic approach to acquisitions and an expansion into emerging markets. The company has consistently delivered strong financial results, reflecting resilience even amidst industry challenges. With an ongoing commitment to research and development, STERIS is well-positioned to leverage trends in healthcare modernization and increasing demand for infection control solutions. As global healthcare systems adapt to rising patient care standards and regulatory requirements, STERIS’s established reputation and forward-thinking strategies make it an attractive investment opportunity for those looking to capitalize on the evolving landscape of healthcare services.

STE Intrinsic Value
225.24 USD
Undervaluation 4%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
18.2%
=
Operating Profit
933.4m
/
Revenue
5.1B
What is the Operating Margin of STERIS plc?

Based on STERIS plc's most recent financial statements, the company has Operating Margin of 18.2%.